about
A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerA repository of assays to quantify 10,000 human proteins by SWATH-MS.Quantitative variability of 342 plasma proteins in a human twin population.Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.Prediction of colorectal cancer diagnosis based on circulating plasma proteinsInference and quantification of peptidoforms in large sample cohorts by SWATH-MS.Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in SerumImage-based computational quantification and visualization of genetic alterations and tumour heterogeneity.TRIC: an automated alignment strategy for reproducible protein quantification in targeted proteomicsMass spectrometric protein maps for biomarker discovery and clinical research.Deep Phosphoproteomic Measurements Pinpointing Drug Induced Protective Mechanisms in Neuronal Cells.Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry.Statistical control of peptide and protein error rates in large-scale targeted data-independent acquisition analyses.Impact of Alternative Splicing on the Human Proteome.On the Dependency of Cellular Protein Levels on mRNA Abundance.A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.Protein kinase D at the Golgi controls NLRP3 inflammasome activation.Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells.Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis.Comparison of targeted proteomics approaches for detecting and quantifying proteins derived from human cancer tissues.Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS.Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer.Genomic, Proteomic and Phenotypic Heterogeneity in HeLa Cells across Laboratories: Implications for Reproducibility of Research ResultsComparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins.Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancerShotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung CancerSimilarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MSIsoform-resolved correlation analysis between mRNA abundance regulation and protein level degradationmotifeR: An Integrated Web Software for Identification and Visualization of Protein Posttranslational Modification MotifsSelection of features with consistent profiles improves relative protein quantification in mass spectrometry experimentsAssessing the Relationship Between Mass Window Width and Retention Time Scheduling on Protein Coverage for Data-Independent AcquisitionCombining Rapid Data Independent Acquisition and CRISPR Gene Deletion for Studying Potential Protein Functions: A Case of HMGN1
P50
Q33759047-13A6E8B8-110E-4EE1-9C6A-5636DDA67A7CQ33850638-78C9379E-87C6-449E-AE8F-A7C64D560685Q34532251-F72D8E78-739E-486E-B7EF-43BEB024946DQ35066504-CDD65236-0126-4B5B-909C-96291BAC45E2Q35174121-867582B6-B9FA-4454-A636-E3575250E918Q35518214-E6A785B6-99DA-475A-ABA6-4670AFB2F72BQ36057583-BF07958D-F1CD-4823-B189-B00EEFE31C4DQ36399003-A39E2287-CB56-4ABD-9DF2-E34EAE46BB63Q36451478-D118C97E-876D-4E44-823B-227DA76F3FADQ36774477-642BD617-AF97-412B-8B41-6F5AC65E963AQ37225838-ED99834E-B588-486E-AD41-B042C89F5757Q37324690-D85D7E15-D092-4D78-BA51-99B2DC03A7FDQ37528700-AB7C5362-E85B-409C-BA8C-9F9C0D561E9AQ38615341-1AF040DD-3020-4A27-B71B-8BEE37BCEE5DQ38616270-F31CFF46-F0BA-4102-8457-569948E912DBQ38646466-BB9729C6-80E9-4F08-BCB1-30487CC82119Q38814866-A2D078ED-FDA1-4035-912D-B01EA3A948D4Q39603617-57EC946A-7849-4F57-8800-F733F6F7B342Q40131186-4C6AFCE9-B841-41C0-A661-54E8131B079BQ42839259-599CEA7C-BA45-47DC-8301-A680212692C8Q42921239-FEFE8DB9-99B6-4464-A43D-28EA94437C47Q51267763-03834FC8-6B10-4114-959A-205EC19FD21EQ54024007-11446C9F-051A-476F-A938-F80CC0EA80E8Q55447045-CC355F79-101F-499B-8E99-F8E8816BC805Q56985329-C92CA2D3-7DC8-41E6-8A30-0E26E4DDF601Q64966563-62A4C444-85B6-4A95-B427-9FA22C0C04CCQ87415962-FA9BC253-CAD5-4D31-AC24-37B46FA05480Q88443466-89E8E2DF-EF43-4716-BE22-907B2034F2C1Q88920933-6E06401D-A23E-4D69-BAA1-96B2FDBF87BCQ90350519-9B7099E3-6B5B-49C9-9D06-64CF13453864Q90768333-5AE39240-7B77-4156-9389-2FA49C0A7ED1Q90803951-F0FDA264-D90A-4941-9DB7-13FFA25014EDQ92421342-9F59294F-E4D9-4440-A4C3-3E6B30B2A6D2Q92552366-A6C28569-A309-4AB2-8380-F3CA65285108
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yansheng Liu
@ast
Yansheng Liu
@en
Yansheng Liu
@es
Yansheng Liu
@nl
type
label
Yansheng Liu
@ast
Yansheng Liu
@en
Yansheng Liu
@es
Yansheng Liu
@nl
prefLabel
Yansheng Liu
@ast
Yansheng Liu
@en
Yansheng Liu
@es
Yansheng Liu
@nl
P1053
E-4786-2018
P106
P1153
36062824100
P31
P496
0000-0002-2626-3912